News
Announcement of an invited speaker at the “Life Sciences Innovation Forum 2025” hosted by King Abdullah International Medical Research Center and J.P. Morgan Asset Management
We are pleased to announce that our Chairman and CEO, Toshio Miyata (Professor, Tohoku University Graduate School of Medicine), was invited to give talks at the “Life Sciences Innovation Forum 2025,” held at the KSAU-HS Convention Center in Riyadh, Saudi Arabia, on October 1 and 2, 2025.
This forum was organized by King Abdullah International Medical Research Center (KAIMRC)1) and co-hosted by the Ministry of Investment of Saudi Arabia (MISA)2) and J.P. Morgan Asset Management3).
The 2025 Life Science innovation Forum is a two-day international event hosted in Riyadh, Saudi Arabia. This prestigious forum serves as a platform to accelerate the conversion of cutting-edge life science research into market-ready solutions. It aims to strengthen the biotechnology value chain by connecting groundbreaking scientific innovators with strategic investors and industry leaders. Aligned with the National Biotechnology Strategy, the forum is designed to foster a thriving, innovation-driven ecosystem that positions Saudi Arabia at the forefront of the global life sciences sector. It has been organized to establish a strong foundation for both regional and global progress in life sciences research, innovation, industry, regulation, and investment.
Our Chairman and CEO, Toshio Miyata, took part in the panel discussion “International Collaboration in Life Sciences” at 10:00 AM (AST) on October 1st, where he spoke about the roles of public research institutions, such as KAIMRC, KAUST and Tohoku University, and startups in medical innovation, and significance of government investment and international collaborative research and clinical development for important medical issues such as longevity. Other panelists included representatives from Saudi Arabia’s government and research institutions, including KAIMRC, MISA, the Saudi Authority for Intellectual Property (SAIP)4), and King Abdullah University of Science and Technology (KAUST)5).
In addition, he gave an invited lecture at a separate session starting at 2:30 PM (AST) on October 1st, where he explained RS5614, a plasminogen activator inhibitor (PAI)-1 inhibitor, a candidate for anti-aging and longevity drug (a novel senolytic drug that eliminates senescent cells and suppresses aging-related diseases without promoting cancer) that our company is developing.
Saudi Arabia is promoting an economic reform initiative known as “Saudi Vision 2030,” which aims to move away from an oil-dependent economy and diversify economic activity accordingly. The primary goal of the healthcare sector under “Saudi Vision 2030” is to improve the productivity, quality, and efficiency of the healthcare system and thereby improve the quality of life of its citizens. Participation and presentations at this forum led to strengthening of collaboration with Saudi Arabian research institutions and government officials.
Lecture on ” International Collaboration in Life Sciences “
1) The King Abdullah International Medical Research Center (KAIMRC) is a leading institution for biomedical and clinical research in Saudi Arabia. KAIMRK provides world-class infrastructure, scientific expertise, and strategic guidance to support innovators and biotech companies from around the globe as they enter the Saudi market. Through close collaboration with government stakeholders, KAIMRC facilitates seamless integration into the national biotechnology landscape. This approach promotes commercialization, knowledge transfer, and long-term partnerships aligned with Saudi Vision 2030.
2) The Ministry of Investment of Saudi Arabia (MISA) is the Kingdom’s lead agency for investment, cultivating a robust, business-friendly ecosystem and ensuring investors are supported at every step of their journey. Guided by Saudi Vision 2030, its mission is to promote Saudi Arabia as a world-class investment destination, attract and expand investments for sustainable economic growth, and help diversify the economy beyond oil. The ministry prioritizes high-impact sectors- such as a healthcare, biotechnology, and technology – to drive innovation and economic diversification, while forging international partnerships that position Saudi Arabia at the forefront of the global investment landscape
3) J.P. Morgan Asset Management plays a crucial role in the biotechnology investment landscape by connecting emerging biotech ventures with global investors. As a strategic partner of this year’s forum, J.P. Morgan is dedicated to supporting the intersection of science and capital. The firm helps unlock opportunities for early-stage life science companies, facilitates access to growth capital, and promotes strategic partnerships to drive innovation across the global biotech industry.
4) The Saudi Arabian Authority for Intellectual Property (SAIP) is a Saudi Arabian government agency responsible for intellectual property rights, including patents, trademarks, and copyrights. It also participates in domestic and international intellectual property policies and international frameworks, contributing to the development of the knowledge economy.
5) King Abdullah University of Science and Technology (KAUST) is a research graduate university established by the Saudi Arabian government, which promotes cutting-edge research in the fields of science, technology, and engineering, fosters international researchers, and promotes collaboration between industry, academia, and government.